N4 Pharma Plc announces that John Chiplin, currently Non-Executive Chairman, is retiring from the Board for personal reasons. Chris Britten, currently a Non-Executive Director of the Company, will assume the role of Non-Executive Chairman of N4 Pharma with effect from 1 August 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.625 GBX | -3.85% | -12.59% | -26.47% |
04-25 | N4 Pharma strikes partnership deal for intracellular delivery | AN |
04-23 | N4 Pharma loss widens but "great optimism" remains | AN |
1st Jan change | Capi. | |
---|---|---|
-26.47% | 2.14M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- ONZ Stock
- News N4 Pharma Plc
- N4 Pharma plc Announces Executive Changes, Effect from 1 August 2023